Clinical Nutrition Market Size

Clinical Nutrition Market Analysis

The Clinical Nutrition Market size is estimated at USD 72.29 billion in 2024, and is expected to reach USD 106.46 billion by 2029, growing at a CAGR of 8.05% during the forecast period (2024-2029).

The COVID-19 pandemic had an effect on the clinical nutrition market. Various studies provide insight into the effects of the pandemic. For instance, in May 2021 a research study published in the National Library of Medicine stated that the prevalence of malnutrition was 42% in patients hospitalized with COVID-19. Thus, such high prevalence provides insight into the lack of nutritional support during the pandemic. Moreover, initiatives such as issuing new guidelines are expected to provide growth to the market over the forecast period. For instance, the European Society for Clinical Nutrition and Metabolism issued guidelines in January 2021, related to nutritional management in ICU patients infected with COVID-19, as clinical nutrition played a crucial role in preventing infection and treating infection-associated malnutrition. Similarly, in February 2021, Tata and Lyle launched Tata & Lyle Nutrition Centre, a new digital hub providing easy access to authoritative science on ingredients that would help food manufacturers address public health challenges. Thus, the market is expected to have a favorable impact during the forecast period of the study.

Certain factors are propelling the clinical nutrition growth of the market, including the increasing prevalence of metabolic disorders, high spending on healthcare, and the rise of the middle class in emerging economies. Over the past decade, the prevalence of metabolic disorders has increased. For instance, the Gaucher's Institute article updated in November 2021 reported that Gaucher disease is equally prevalent in males and females and has a worldwide prevalence of 0.70 to 1.75 per 100,000 individuals. The same source also reported that the standardized birth incidence of Gaucher disease within the general population varies from 0.39 to 5.80 per 100,000 individuals. Such a burden of diseases creates the need for clinical nutrition products and thus drives the growth of the market. During surgeries, clinical nutrition plays a major part in minimizing patient adverse consequences and enabling surgeons to work in a controlled environment. According to the Organization for Economic Co-operation and Development updated in August 2022, the number of surgeries (in thousand) performed in some European countries such as Portugal, Denmark, Ireland, and Norway in 2021 include 94.87, 49.33, 32.84, 21.5. Thus, with the rising burden of diseases and the volume of surgeries, the clinical nutrition market is expected to boost during the forecast period.

Similarly, product launches are another factor in market growth. For instance, in August 2021, Esperer Nutrition launched a range of consumer nutraceuticals for bone and joint health, immunity, urinary tract health, sleep apnea, and pre-diabetic care. Such product launches are expected to increase the adoption of clinical nutrition which is expected to increase market growth over the forecast period. Hence, the growing number of the elderly population and the development of clinical nutrition products specific to the aging population are expected to boost market growth.

However, imprecise perceptions about clinical nutrition and reduction in birth rates are expected to hinder the market growth.